Trial Profile
Effect of decitabine in myeloproliferative neoplasm in blastic phase/acute myeloid leukemia and accelerated phase (mpn-ap), and dipss-plus high risk primary myelofibrosis patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Jul 2015
Price :
$35
*
At a glance
- Drugs Decitabine (Primary)
- Indications Acute myeloid leukaemia; Myelofibrosis; Myeloproliferative disorders
- Focus Therapeutic Use
- 03 Jul 2015 New trial record